Rebecca L. Rohde

Rebecca L. Rohde

Auto-generated profile, based on publicly available information

Rebecca L. Rohde

Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Cureus
Verified
Journal Article
Open access
EREric Rohe
Eric Rohe
MGMalia Gresham
Malia Gresham
RRRebecca Rohde
Rebecca Rohde
LCLauren Cass
Lauren Cass
JBJennifer V. Brinkmeier
Jennifer V. Brinkmeier
ACAdrienne Childers
Adrienne Childers
Management of patients with post-tonsillectomy hemorrhage (PTH) is not well defined but may include observation, topical bedside treatments, or return to the operating room. Data on the use and efficacy of silver nitrate as a topical bedside agent for the management of PTH remain unexplored. Our primary objective was to assess the efficacy of silver nitrate in reducing the need for operative control of PTH. Single-institution retrospective chart review included patients aged 5-18 years who presented with tonsillar bleeding within 30 days of tonsillectomy. Patients undergoing observation or bedside silver nitrate cautery were compared based on clinical characteristics and experience of the physician performing the procedure. The outcome of interest was rebleeding requiring operative control. Sample characteristics according to treatment modality were described using Fisher’s exact tests and ANOVA. Of the patients eligible for inclusion, 29 (20%) were observed and 70 (48.3%) were treated with topical silver nitrate. Age was the only statistically significant clinical difference among treatment groups. The silver nitrate group had more patients who underwent operative control of PTH compared to the observation group (p = 0.004). When comparing the need for operative control between the observation group and patients who had initial success with silver nitrate, there was no difference (p = 0.29). No differences were found in the rate of bleeding requiring operative control when comparing experience of the physician performing the procedure (p = 0.20). More patients who underwent silver nitrate cautery required PTH control in the operating room compared to the observation group. This may be due to patient selection as our results also suggest that there is no statistical difference in rates of operative control of PTH when comparing initial successful treatment with topical silver nitrate to observation. Age is likely a factor that was used by physicians in this study to decide the initial management of PTH. Provider experience does not appear to affect rebleeding rates. Future studies are necessary to evaluate the clinical impact of silver nitrate in the context of PTH and will benefit from more robust sample sizes and enhanced diversity in the sample group.

1 March 2023 in JCO Oncology Practice
Verified
Journal Article
Open access
JCJulia E. Canick
Julia E. Canick
ABArun Bhardwaj
Arun Bhardwaj
APAmila Patel
Amila Patel
DKDuaa Kuziez
Duaa Kuziez
RLRylan Larsen
Rylan Larsen
NONosayaba Osazuwa-Peters
Nosayaba Osazuwa-Peters
PURPOSE: While pain is prevalent among survivors of head and neck cancer (HNC), there is a lack of data on pain management in the community oncology setting. We described sociodemographic correlates and disparities associated with patient-reported pain among patients with HNC. METHODS: We used the 2017-2021 nationwide community oncology data set from Navigating Cancer, which included electronic patient-reported outcomes. We identified a retrospective cohort of patients diagnosed with HNC (N = 25,572), with ≥ 1 patient-reported pain event. We adjusted for demographic (sex, age, smoking history, marital status) and clinical (cancer site) factors associated with pain reporting and pain resolution by new pain prescription on the basis of race (White v non-White patients), using multivariate logistic regression models. RESULTS: Our analytic cohort included 2,331 patients, 90.58% White, 58.62% married, with an average age of 66.47 years. Of these, 857 patients (36.76%) reported ≥ 1 pain event during study period. Mean resolution time (in minutes) for pain incidents was significantly longer for White patients than non-White patients (99.6 ± 3.2 v 74.9 ± 7.2, P < .05). After adjusting for covariates, smoking was associated with a 25% increased odds of reporting pain incidents (adjusted odds ratio [aOR], 1.25; 95% CI, 1.03 to 1.52). There was no statistically significant difference in odds of pain reporting between White versus non-White patients (aOR, 0.97; 95% CI, 0.73 to 1.30). However, White patients were significantly more likely to receive new prescription for pain than non-White patients (aOR, 2.52; 95% CI, 1.09 to 5.86). CONCLUSION: We found racial differences in patient-reported pain management, with White patients significantly more likely to receive new pain prescriptions. As pain management is a mainstay in cancer care, equity in pain management is critical to optimize quality of life for patients with HNC.

24 November 2019 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
RRRebecca L. Rohde
Rebecca L. Rohde
DCDary J. Costa
Dary J. Costa
JBJennifer V. Brinkmeier
Jennifer V. Brinkmeier

21 August 2023 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
LNLauren M. North
Lauren M. North
RRRebecca L. Rohde
Rebecca L. Rohde
SCSarah Cornell
Sarah Cornell
CLChristopher M. Long
Christopher M. Long
NZNathan T. Zwagerman
Nathan T. Zwagerman

3 May 2024 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
RRRebecca L. Rohde
Rebecca L. Rohde
JMJess C. Mace
Jess C. Mace
LNLauren M. North
Lauren M. North
KMKatie Melder
Katie Melder
TSTimothy L. Smith
Timothy L. Smith
DPDavid M. Poetker
David M. Poetker

1 March 2024 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
TLTongtong Lu
Tongtong Lu
PKPawjai Khampang
Pawjai Khampang
ABAhmed Sam Beydoun
Ahmed Sam Beydoun
ABAnna Berezovsky
Anna Berezovsky
RRRebecca Rohde
Rebecca Rohde
JKJoseph E. Kerschner
Joseph E. Kerschner
SignificanceEndotracheal intubation is a common approach for airway management in critically ill patients. However, the position of the endotracheal tube (ETT) may be altered during the procedure due to head movements. Accidental displacement or dislodge of the ETT may reduce the airflow, leading to moderate to severe complications, and in some cases even fatality. Therefore, timely detection of changes in ETT position in the trachea is critical to ensure immediate and intermediate interventions to maintain the ETT in the proper position. Currently, there are no widely utilized tools for real-time monitoring of ETT positions.AimThe goal of this study is to develop a cost-effective and easy-to-use near-infrared (NIR) device, named Opt-ETT, capable of continuously monitoring the ETT position in the trachea of a patient.ApproachA side-firing fiber is attached to the side of the ETT to illuminate the trachea tissue with NIR light, and a detector board containing five phototransistors is affixed to the chest skin to measure the intensity of diffusely transmitted light. Displacement of the ETT is estimated using second-order polynomial fitting to the ratios of the phototransistor readings. Monte Carlo simulations, ex vivo experiment on porcine tissue, and in vivo experiments using a swine model have been conducted to assess the feasibility of the device.ResultsThe design of the Opt-ETT device has been verified by the Monte Carlo simulations and ex vivo experiment. The estimation of displacement from in vivo experiments using the Opt-ETT exhibited a high degree of agreement with that measured by a reference sensor, with a discrepancy between −1.0 to +1.5 mm within a displacement range from −15 to +15 mm.ConclusionsThe Opt-ETT device provides a potentially cost-effective solution for real-time and continuous monitoring of ETT position in patient during an intubation procedure.